ArticleVaccines2021

COVID-19 Subunit Vaccine with a Combination of TLR1/2 and TLR3 Agonists Induces Robust and Protective Immunity.

Soo-Kyung Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.